A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

NCT06591598 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema
Neovascular Age-related Macular Degeneration

Interventions

DRUG: Aflibercept (BAY86-5321, Eylea)

Sponsor

Bayer

Collaborators

[object Object]